Arent v. Shalala’s Empirical Analysis
1995
Citation profile
Relationships
Relies on Conley v. Gibson · Chevron U. S. A. Inc. v. Natural Resources Defense Council, Inc. · Citizens to Preserve Overton Park, Inc. v. Volpe · Motor Vehicle Manufacturers Association of United States Inc v. State Farm Mutual Automobile Insurance Company Consumer Alert · Abbott Laboratories v. Gardner
Most-quoted passages
The sentences later courts lift from this opinion, ranked by how many decisions quote each — the parts of the opinion doing the work. These counts are smaller than the citation total above because most of the 1 citing decisions cite the case generally; a passage count includes only decisions quoting that exact language verbatim.
“comply with the labeling guidelines 2 In several cases, this court has analyzed challenges based on Chevron and State Farm in separate and distinct inquiries. See, e.g., National Recycling Coalition, Inc. v. Browner, 984 F.2d 1243 , 1250-52 (D.C.Cir.1993); Solite Corp. v. United States EPA, 952 F.2d 473 , 482-88 (D.C.Cir.1991); City of Kansas City, Mo. v. HUD, 923 F.2d 188 , 191-94 (D.C.Cir.1991) 3 This type of case is rare, though; this court has found that phrases as broad as”
1 later decision quote this exact passage · from the concurrencee.g. Arent v. Shalala“and cited to State Farm, I read these references as made in the context of a Chevron step two analysis. See, e.g., Brief for Appellants at 20-39 (arguing that FDA regulation violates statutory directive, but contending that typical Chevron deference is unwarranted because FDA did not rely on agency expertise in promulgating regulation); Brief for Appellees at 23 (arguing that trial court's ruling should be upheld because”
1 later decision quote this exact passage · from the concurrencee.g. Arent v. Shalala“under the NLEA does not represent an enforcement action. 11 In light of our conclusion that this court has jurisdiction to review the FDA's determination regarding the standards for measuring retailer compliance with the NLEA's voluntary food labeling guidelines, we turn to the merits of appellants' challenges to the FDA's industry-wide and individual compliance standards. 12 B. The Industry-Wide”
1 later decision quote this exact passagee.g. Arent v. Shalala
How this case has been treated — in progress
Whether each later court followed, distinguished, criticized, or overruled this decision. The treatment classification (task #35) runs highest-cited cases first and lights up here as it reaches this one.